Critically ill COVID-19 infected patients exhibit increased clot waveform analysis parameters consistent with hypercoagulability

American Journal of Hematology

Volumn 95, Issue 7, 2020, Pages E156-E158

  Tan, Chuen Wen ^a,b   Low, Jenny Guek Hong ^a,c   Wong, Wan Hui ^a   Chua, Ying Ying ^a,b   Goh, Sher Li ^b   Ng, Heng Joo ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

^b Sengkang General Hospital   (Singapore)

^c DUKE NUS MEDICAL SCHOOL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; D DIMER; PROCALCITONIN; FIBRIN DEGRADATION PRODUCT; FIBRIN FRAGMENT D;

ACTIVATED PARTIAL THROMBOPLASTIN TIME; ADULT; BLOOD CLOTTING PARAMETERS; CLINICAL ARTICLE; CLOT WAVEFORM ANALYSIS; CORONAVIRUS DISEASE 2019; CRITICALLY ILL PATIENT; DISEASE SEVERITY; HEMOSTASIS; HUMAN; HYPERCOAGULABILITY; HYPERLIPIDEMIA; HYPERTENSION; INTENSIVE CARE UNIT; LETTER; MIDDLE AGED; PRIORITY JOURNAL; THROMBOSIS PREVENTION; VIRAL RESPIRATORY TRACT INFECTION; BETACORONAVIRUS; BLOOD; COMPLICATION; CORONAVIRUS INFECTION; CRITICAL ILLNESS; MALE; PANDEMIC; PARTIAL THROMBOPLASTIN TIME; THROMBOPHILIA; VIRUS PNEUMONIA;

ADULT; BETACORONAVIRUS; C-REACTIVE PROTEIN; CORONAVIRUS INFECTIONS; CRITICAL ILLNESS; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; MALE; MIDDLE AGED; PANDEMICS; PARTIAL THROMBOPLASTIN TIME; PNEUMONIA, VIRAL; THROMBOPHILIA;

EID: 85083261601     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.25822     Document Type: Letter

References (7)

1. Smeeth L, Cook C, Thomas S, Hall AJ, Hubbard R, Vallance P. Risk of deep vein thrombosis and pulmonary embolism after acute infection in a community setting. Lancet. 2006;367(9516):1075-1079. https://doi.org/10.1016/S0140-6736(06)68474-2
2. VAN WISSEN M, KELLER TT, VAN GORP ECM, et al. Acute respiratory tract infection leads to procoagulant changes in human subjects. J Thromb Haemost. 2011;9(7):1432-1434. https://doi.org/10.1111/j.1538-7836.2011.04340.x
3. Liu Q, Zhou YH, Yang ZQ. The cytokine storm of severe influenza and development of immunomodulatory therapy. Cell Mol Immunol. 2016;13(1):3-10. https://doi.org/10.1038/cmi.2015.74
4. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497-506. https://doi.org/10.1016/S0140-6736(20)30183-5
5. Tan CW, Cheen MHH, Wong WH, et al. Elevated activated partial thromboplastin time-based clot waveform analysis markers have strong positive association with acute venous thromboembolism. Biochem Med. 2019;29(2):020710. https://doi.org/10.11613/BM.2019.020710
6. Foley JH, Conway EM. Cross Talk Pathways between Coagulation and Inflammation. Circ Res. 2016;118(9):1392-1408. https://doi.org/10.1161/CIRCRESAHA.116.306853
7. Lawrence Ng CK, Tan CW, Cheen HHM, Wong WH, Chu MHY, Lim SS, Yeo GDD, Morvil G, Joo Ng H. APTT-based clot waveform analysis in various infections. EHA Library. 2018;215813:PS1530.